Otter J A, Tosas-Auguet Olga, Herdman M T, Williams B, Tucker D, Edgeworth J D, French G L
Centre for Clinical Infection and Diagnostics Research (CIDR), Department of Infectious Diseases, King's College London, and Guy's and St Thomas' Hospital NHS Foundation Trust London, UK.
Centre for Clinical Infection and Diagnostics Research (CIDR), Department of Infectious Diseases, King's College London, and Guy's and St Thomas' Hospital NHS Foundation Trust London, UK.
J Hosp Infect. 2014 Jul;87(3):171-4. doi: 10.1016/j.jhin.2014.04.005. Epub 2014 May 10.
Universal admission screening for meticillin-resistant Staphylococcus aureus (MRSA) has been performed in England since 2010. We evaluated the predictive performance of a regression model derived from the first year of universal screening for detecting MRSA at hospital admission. If we had used our previous targeted screening policy, 75% fewer patients (21,699 per year) would have been screened. However, this would have identified only ~55% of all MRSA carriers, 65% of healthcare-associated MRSA strains, and 40% of community-associated strains. Failing to identify ~45% of patients (262 per year) carrying MRSA at hospital admission may have implications for MRSA control.
自2010年以来，英格兰已对耐甲氧西林金黄色葡萄球菌（MRSA）进行了普遍入院筛查。我们评估了从普遍筛查第一年得出的回归模型在检测入院时MRSA方面的预测性能。如果我们采用之前的目标性筛查政策，接受筛查的患者将减少75%（每年21,699例）。然而，这只能识别出所有MRSA携带者的约55%、医疗保健相关MRSA菌株的65%以及社区相关菌株的40%。未能识别出约45%（每年262例）入院时携带MRSA的患者可能会对MRSA的控制产生影响。
